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ABSTRACT  
OBJECTIVE: 
Phenylethyl resorcinol (PR) has been used widely in the personal care industry as a novel skin lightening 
ingredient. Surprisingly, there is only limited information describing the physicochemical properties of 
this active. Therefore, the primary objective of this study was to perform a comprehensive 
characterization of PR. A secondary objective was to investigate the delivery of this molecule to 
mammalian skin.  
 
METHODS: 
PR was characterised using Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), 
and Nuclear Magnetic Resonance (NMR). A new high-performance liquid chromatographic (HPLC) 
method for analysis of PR was developed and validated. The logP (octanol water partition coefficient), 
value, solubility and short-term stability of PR in a series of vehicles were also determined using HPLC. 
The evaporation of the selected vehicles was examined using Dynamic Vapour Sorption (DVS). The 
permeation profiles of PR were investigated under finite dose conditions in porcine and human skin.  
 
RESULTS: 
The melting point of PR was determined to be 79.13 °C and the measured logP (octanol water partition 
coefficient) at 21 °C was 3.35 ± 0.03. The linearity of the HPLC analytical method was confirmed with 
an r2 value of 0.99. Accuracy of the method was evaluated by average recovery rates at three tested 
concentrations, and the values ranged from 99 – 106%. The limit of detection (LOD) and limit of 
quantification (LOQ) were 0.19 and 0.57 g/mL, respectively. The solubility of PR in PG, DMI, glycerol 
was within the range of 367 to 877 mg/mL. The stability of PR in tested solvents were also confirmed by 
the 72 h stability studies. From the DVS studies, 70-125% of applied formulations were recovered at 24h. 
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The permeation through porcine skin at 24 h ranged from 4 to 13 g/cm2, while the corresponding 
amounts of PR delivered through human skin were 2 to 10 g/cm2. 
 
CONCLUSION: 
The physicochemical properties of PR confirm it is suitable for dermal delivery. In this study, propylene 
glycol was the most promising vehicle for PR delivery to human skin. Future work will expand the range of 
vehicles studied and explore the percutaneous absorption from more complex formulations.  
 
 
Introduction 
Melanin is the primary pigment responsible for the variation of colour observed in the skin, eye and hair of 
humans [1, 2]. Melanin is an aggregate of smaller nitrogenous molecules; it is produced within cell 
melanocytes located in basal layer of epidermis and transferred to keratinocytes throughout the epidermis 
[3, 4]. There are two types of melanin pigments found in human skin, the brown to black eumelanins and 
the red to yellow sulfur pheomelanins [5]. Skin darkness is directly related to the amount of eumelanin 
present, while melanocytes can produce varying ratios of eumelanin and pheomelanin in the process of 
melanogenesis [6]. It is believed that skin pigmentation has a photoprotective function; researchers have 
discovered that the two types of melanin appear to play different roles in this function [7]. Eumelanin 
serves as a physical barrier that scatters ultraviolet radiation (UVR) and as an absorbent filter that 
reduces the penetration of UV photons through the epidermis [8]. Pheomelanin shows weak 
photoprotective capability against UVR relative to eumelanin [9]. A deficiency in melanin can result in a 
series of dermatological problems, congenital hypopigmentation disorders including various types of 
oculocutaneous albinism and acquired hypopigmentation disorders such as vitiligo and Sutton nevus [10]. 
On the other hand, excess accumulation and uneven distribution of melanin is associated with 
dermatological conditions such as melasma [11]. Thus, developing safe and efficient treatments for 
unwanted skin pigmentation has attracted interest from both the cosmetic and pharmaceutical sectors 
[12].  
  
Inhibitors of melanin synthesis and tyrosinase activity have been reviewed previously [6, 13-16]. Melanin 
is synthesized in the process of melanogenesis. Melanogenesis is a complex biosynthetic pathway 
involving a series of enzymatic catalyzed and chemical reactions. Three enzymes, tyrosinase, 
tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2 (TRP-2, also known as 
dopachrome tautomerase, DCT), play crucial roles in melanogenesis [6]. Initial melanin synthesis is 
catalyzed by tyrosinase, with the oxidation of L-tyrosine to dopaqionone (DQ) and /or 
L-dihydroxyphenylalanine (L-DOPA) to DQ which is the substrate for both eumelanin and pheomelanin 
synthesis (Fig. 1) [14]. Tyrosinase is a membrane-bound copper-containing glycoprotein (EC 1.14.18.1). 
At physiological pH, the remainder of the melanogenesis reaction sequence can spontaneously proceed, 
thus regulation of tyrosinase is a strategy for modulation of hyperpigmentation [16].    
 
Phenylethyl resorcinol (PR, also known as 4-(1-phenylethyl)1,3-benzenediol) is a phenolic compound 
(Fig. 2) developed as a tyrosinase inhibitor [17, 18]. It inhibits tyrosinase activity and also demonstrated 
antioxidant benefits in cell culture studies [17, 19]. PR showed more than 20-fold efficiency in inhibition 
of mushroom tyrosinase compared with kojic acid. A concentration of 0.1% of PR resulted in almost 
complete suppression of melanin synthesis after 14 days application to pigmented 3D epidermis models 
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[18]. An in vivo study examined the efficacy of a formulation containing PR and other actives as an 
alternative to hydroquinone and kojic acid in 2012 [20]. After a 4-week washout period with a sunscreen, 
20 female patients with mild-to-moderate melasma were treated with an oil-in-water emulsion cream 
containing disodium glycerophosphate, L-leucine, PR, and undecylenoyl phenylalanine for a 12-week 
period. The same daily sunscreen was consistently used during the treatment period. The facial skin of 
the patients was evaluated before and after the washout period and after the 12-week treatment period. 
There was no significant change in skin pigmentation during the 4-week washout; signs for uneven skin 
tone including appearance of lentigines and melasma area and severity index (MASI) decreased by up to 
43% after the treatment. A later in vivo study investigated the same cream with a larger sample size [21] 
The formulation was assessed for its effects on photoaging in 80 female subjects using visual assessment. 
After a 12-week application period, improvements in signs of facial skin discoloration were reported. 
However, there were significant limitations to this study, including the lack of a control group and 
evaluation of changes in pigmentation with subjective measurements. More recently, a number of 
publications have focused on the formulation of advanced carriers containing PR [22-24]. Fan and 
colleagues developed PR loaded nanostructured lipid carriers (PR-NLC) using a high-pressure 
homogenization approach [24]. Limsuwan and colleagues [23] designed Ethosome formulations containing 
0.5% (w/v) PR, 0.5 % (w/v) cholesterol, 3% (w/v) L- -phosphatidylcholine, 30% (v/v) absolute ethanol, 
and water up to 100% (v/v); the in vitro permeation of PR was subsequently evaluated using newborn pig 
skin with a application of 1 mL of 0.5 mg/mL PR-Ethosome formulation. At 24 h, the cumulative 
permeated amount of PR through skin was 58.7 g/cm2. This appears to be the first study that 
investigated the permeation behaviour of PR in vitro. However, the experiment was conducted under 
infinite dose conditions and does not simulate typical amounts of a topical formulation that consumers 
apply to skin [25, 26]. Recently, Kang and Park [27] probed the mechanism of the anti-melanogenic 
activity of PR via a series of in vitro assays including assessment of cell survival, melanin content, cellular 
tyrosinase activity, real-time PCR analysis, luciferase-reporter assay, Western blot analysis, and ELISA 
assay of cyclic AMP (cAMP), protein kinase A (PKA), cAMP response element binding (CREB) protein, 
and mitogen-activated protein kinases (MAPKs). These authors reported that PR can attenuate 
melanogenesis by activating p44/42 MAPK which is a kinase that regulates signaling pathways mediating 
melanogenesis in melanocytes.  
 
Despite these reported in vitro and in vivo studies of the biological effects of PR, there is little 
information in the literature with reference to the physicochemical properties of this compound. 
Therefore, the primary objective of this study was to undertake a comprehensive characterization of PR. 
As the skin penetration and delivery of PR to the skin is also not well understood, or documented, a 
secondary objective of the present work was to examine delivery of the molecule to mammalian skin from 
a range of solvents and permeation enhancers widely used in personal care products.  
  
Materials and methods 
Materials 
Phenylethyl resorcinol (Symrise, Holzminden, Germany) was a gift from pION Inc. Billerica, USA. 
Methanol, propylene glycol (PG) and glycerol were purchased from Fisher Scientific, UK. Dimethyl 
isosorbide (DMI) was kindly donated by Croda Ltd. (Goole, UK). Porcine tissue was supplied by a local 
abattoir. Excised abdominal human tissue was obtained from the UK Human Tissue Bank with appropriate 
institutional and ethical approval.  
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Nuclear Magnetic Resonance (NMR) 
1H NMR and 13C NMR were recorded using a Bruker DMX-500 spectrometer operating at 500 MHz for 
proton and 126 MHz for carbon. Chemical shifts (H and C) are quoted as parts per million downfield from 
0. The multiplicity of 1H NMR signals are designated by one of the following abbreviations: s = singlet, d 
= doublet, t = triplet, q = quartet and m = multiplet, and coupling constants (J) are expressed in Hertz. All 
data was processed using MestReNova® 9.0.1 (Mestrelab Research, Spain). PR was dissolved in 
Chloroform-d (CDCl3).   
 
Thermal analysis 
The melting point of PR was examined using thermogravimetric analysis (TGA, TA Instruments, U.S.A.) 
and differential scanning calorimetry (DSC, TA instruments, USA). A suitable amount of PR was weighed 
in an open aluminium pan (TA Instruments, U.S.A.) and then heated inside the TGA furnace. The mass 
change of PR as a function of temperature increase was recorded. The initial temperature and the terminal 
temperature were set to 40 and 400°C with a heating ramp of 20 °C/min. A nitrogen flow of 25 mL/min 
was supplied throughout the experiment to maintain an inert environment around the sample. To conduct 
DSC analysis, PR was weighed in a hermetic aluminium pan (TA Instruments, U.S.A.) and then 
subsequently sealed with a hermetic aluminium lid (TA Instruments, U.S.A.) using a Tzero™ press (TA 
Instruments, U.S.A.). The PR sample was heated from 0 to 150 °C at 10 °C/min under nitrogen (50 
mL/min)  supplement throughout the measurement. TA Universal software was used for data analysis. 
 
Dynamic vapour sorption studies and preparation of PR solutions  
To study the evaporation or hydration of the vehicles, a Q5000 SA sorption analyzer (TA Instruments, 
U.S.A.) was used to examine the mass differences over 24 h. Nitrogen was used as the carrier gas at a 
flow rate at 200 mL/min. Temperature and relative humidity (RH) were maintained throughout the 
experiment at 32 ± 1°C and 50 ± 2% RH, respectively. Solutions of PR (1% w/v) were prepared in PG, 
DMI and glycerol. 
 
UV, HPLC analysis and method validation 
To identify the wavelength number at which the absorption of light was selective for PR, a spectronic 
BioMate™ 3 UV/vis spectrophotometer (Thermo Scientific, U.S.A.) was used to conduct an UV scan of a 
solution of the active between 200 and 300 nm (step=1 nm). PR quantification was conducted using a 
HPLC (Agilent 1100, Agilent technologies, U.S.A., operated with ChemStation® Rev.A.09.03). The 
compound was analyzed with a Kinetix 5 m C18 100 x 4.6 mm reverse phase column (Phenomenex, U.K.). 
The mobile phase consisted of methanol: water (60:40). The injection volume was set as 20 L, the flow 
rate at 1 mL/min and the column temperature was 30 °C. This method was validated according to 
guidelines established by the International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use [28]. Linearity, specificity, accuracy, precision, lower 
limit of detection (LOD) and lower limit of quantification (LOQ) of the developed analytical methods were 
also determined.   
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The logP (octanol water partition coefficient), solubility and stability determination 
The shake flask method was used to determine the partition coefficient of PR [29]. Octanol pre-saturated 
with water and water pre-saturated with octanol was prepared by mixing water and octanol in two stock 
bottles, one containing 100 mL octanol and a sufficient quantity of water, and the other containing 100 
mL of water and a sufficient quantity of octanol. After stirring for 24 h at room temperature, 21°C , and 
equilibration for 48 h, the phases were separated. A stock solution of 100 mg/mL of PR in the saturated 
octanol layer was prepared. Three saturated octanol solutions of PR were prepared at 1 mg/mL with 
three different ratios of octanol: water (1:1, 1:2, 2:1). Vessels were agitated for 5 min, and the aqueous 
and organic phases were separated after 48 h. A sample from each phase was diluted and analysed by 
HPLC to calculate the log P as shown in Equation (1), where Coctanol is the concentration of PR in the 
organic phase and Caqueous is the concentration in the aqueous phase. All measurements were conducted in 
triplicate. 
 
          
        
        
                                                           (1) 
 
The solubility of PR in a series of vehicles was estimated by adding an excess amount of active into 
screw-cap glass vials containing a fixed amount of vehicle (2 mL, n=3). These vials were sealed with 
Parafilm® and placed in a water bath at 32±1 °C for 48 h. A series of solvents including propylene 
glycol (PG), dimethyl isosorbide (DMI), and glycerol were selected for solubility determinations. The 
solubility of PR in PBS solution was also evaluated. The short-term stability of PR in the selected vehicles 
was examined over 72 h at 32±1 °C. PR solutions were prepared at a concentration of 1 % (w/v) and the 
samples were analyzed by HPLC at time zero and at 24 h intervals up to 72 h.   
 
In vitro permeation studies and mass balance studies 
The in vitro permeation studies of PR were conducted using vertical glass Franz diffusion cells as 
reported elsewhere [25, 30]. 1 % (w/v) solutions PR in three vehicles, namely PG, DMI and glycerol, were 
prepared. The permeation was initially performed under finite dose conditions (5 L/cm2) using full 
thickness porcine ear skin [31]. Subsequently the permeation behaviour was investigated using heat 
separated human epidermal membranes under the same dosing conditions. Porcine tissue was obtained 
from a local abattoir. Full-thickness skin was surgically removed from cartilage using scalpel as described 
by Caon et al [32]. Human epidermal membranes were prepared by heat separation as described 
previously [33]. Heat separation of porcine skin was not carried out as it has been shown to compromise 
the membrane integrity. Skin samples were stored at – 20 °C until required. Skin integrity was examined 
by electrical resistance assessment before use [31]. Approximately 2 mL freshly prepared PBS solution 
(pH 7.3 ± 0.1) was used as the receptor medium and solubility determination confirmed that sink 
conditions were maintained throughout the experiments [34]. Franz cells were placed in a 
thermostatically controlled water bath (JB Nova, Grant, UK) set at 36±1 °C and the temperature of the 
membrane was measured routinely until it equilibrated at 32±1 °C (TM-22 Digitron digital 
thermometer, RS Components, Corby, UK). 5 L/cm2 of PR solutions were added into the donor 
chamber when the skin surface had equilibrated. Permeation studies were conducted up to 24 h. 200 L 
of receptor medium was withdrawn at each sampling interval (2, 4, 6, 8, 10, 12 and 24 h) and a same 
volume of fresh PBS solution was added to maintain a constant volume. All samples were analysed by 
HPLC.  
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Mass balance studies were conduct to examine the distribution of the active and to determine the total 
recovery [35]. The receptor medium was removed immediately once the permeation studies were 
complete. The skin surface was washed by adding 1 mL of water: methanol (10:90) three times for the 5 
L/cm2 application. For each washing, the washing solution was transferred into an Eppendorf® tube. A 
cotton bud was used to swab the skin surface and the cotton bud was placed in Eppendorf® tubes with 1 
mL of water: methanol (10:90). To extract PR contained in the skin, skin was removed from the Franz 
cells and cut into small pieces. These skin pieces were collected and put in Eppendorf® tubes with 1 mL of 
water: methanol (10:90). The Eppendorf® tubes were placed in an orbital shaker overnight at room 
temperature. Samples for skin extraction measurement were centrifuged at 13,200 rpm at room 
temperature for 20 min and all other samples were centrifuged at 12,000 rpm for 13 min. The supernatant 
solution was analyzed by HPLC. The mass balance approach was validated in advance of the study (data 
not shown). Results were calculated using Equation 2, where T is total recovery, W represents the 
recovery from the skin surface by washing and swabbing using the cotton bud, E is the value for skin 
extraction and P is the recovery from the receptor medium.  
 
                                                                     (2) 
 
Statistical analysis  
Data were plotted using Microsoft® Excel. The statistical analysis was conducted using SPSS® Statistics 
Version 24 (IBM, USA). The data were examined for normality using the Shapiro-Wilk Test, and the 
homogeneity of variance was assessed using Levene’s test. For data that meet the assumptions of 
normality and homogeneity of variance, one-way ANOVA was performed. Tukey’s HSD post hoc test 
was used after ANOVA analysis to perform pairwise analysis. For non-parametric data or where the 
assumption of homogeneity of variance between groups was violated in the ANOVA analysis, the 
Kruskal-Wallis H test was used. A p-value lower than 0.05 (p<0.05) was considered a statistically 
significant difference. All the results are presented as mean ± standard deviation. 
 
 
Results and discussion 
 
NMR 
The 1H and 13C NMR spectrums of PR in chloroform-d are shown in Fig. 3. The structure was assigned 
and confirmed as follows: 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H, Ar-CH), 7.28 – 7.21 (m, 3H, 
Ar-CH), 7.12 (d, J = 8.3 Hz, 1H, Ar-CH), 6.45 (dd, J = 8.3, 2.6 Hz, 1H, Ar-CH), 6.32 (d, J = 2.5 Hz, 1H, 
Ar-CH), 4.64 (s, 1H, OH), 4.63 (s, 1H, OH), 4.27 (q, J = 7.2 Hz, 1H, CH3-CH), 1.62 (d, J = 7.2 Hz, 3H, 
CH3-CH); 
13C NMR (126 MHz, CDCl3) δ 155.10 (Quaternary-C), 154.34 (Quaternary-C), 145.47 
(Quaternary-C), 128.78 (Aromatic-C), 128.63 (Aromatic-C), 127.41 (Aromatic-C), 126.54 (Aromatic-C), 
124.31 (Quaternary-C), 107.62 (Aromatic-C), 103.54 (Aromatic-C), 38.39 (CH), 21.30 (CH3). 
 
Thermal analysis  
TGA measurement was conducted ahead of DVS investigation. There was no weight loss of PR up to 
213.3 °C, which indicated the degradation occurs at 213.3 °C (Fig.4). As shown in Fig. 5, the onset 
temperature of the melting point and the enthalpy of fusion were measured as 79.1 °C and 113.6 J/g, 
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respectively. Furthermore, the purity of the PR sample was confirmed by the single endothermic event in 
the DSC curve in Fig. 5.  
 
DVS results 
Fig. 6 shows the DVS results for all PR solutions over 1440 min at 32±1°C and 50 % RH. Initially, an 
increase in weight was observed for all three tested solutions. This can be explained by the hygroscopic 
nature of PG, DMI and glycerol. The mass of PG and DMI solutions started to decrease at 67.2 and 43.1 
min, respectively. The evaporation of PG was consistent with previous studies [36, 37]. The amounts of 
DMI, PG and glycerol vehicles remaining at 1440 min were 69.5±2.4, 48.4±3.0, and 124.0±1.6%, 
respectively.   
 
UV, HPLC analysis and method validation 
The detection wavelength for UV detection of PR was selected as 280 nm. For the HPLC analytical 
method validation, a calibration curve ranging from 0.25 to 50 g/mL was constructed. The correlation 
coefficient (r2) was 0.99 confirming the linearity of the method. The accuracy of this method was 
evaluated by spiking PR at three concentrations (1, 25, 50 g/mL). The recovery rates within the range 
of 99.16 – 105.77% indicated this method was accurate for PR. The precision was evaluated by 
determination of inter-day variability and intra-day repeatability. The % relative standard deviation (RSD) 
values of intra-day variability studies were < 1.50 %; while the % RSD results of inter-day precision were < 
1.15 %. Based on the standard deviation and slope determination strategy, the limit of detection and limit 
of quantification were 0.19 and 0.57 g/mL, respectively. 
 
logP (octanol water partition coefficient), solubility and stability determinations 
The mean value of the log P for the three octanol:water ratios evaluated was determined to be 3.35±0.03 
at room temperature (21 °C). This experimental value is in line with the predicted logP values. 
DrugBank published the calculated logP for PR as 3.74 and 3.02 using ChemAxon and ALOGPS, 
respectively [38]. Table I shows the results for the solubility studies. The solubility of PR in DMI, PG, 
glycerol was determined to be 877.1, 568.0 and 367.8 mg/mL. The solubility of PR in PBS solution was 
determined as 3.4 mg/mL. This confirmed that sink conditions would be maintained over the course of 
the permeation study. A concentration of 1% of PR in DMI, PG, or glycerol was selected as this within the 
range of the concentration found in the marketed products [39]. The stability of PR in DMI, PG, and 
glycerol was also evaluated at 32±1 °C. After 72h, the recovery values of PR were > 93.0 %. The 
stability of PR in PBS solutions was also confirmed (Fig. 7).   
 
Permeation studies  
The permeation behaviour of PR was investigated using both full thickness porcine skin with a comparable 
thickness of 1.45 ± 0.40 mm and heat separated human epidermal membranes under finite dose 
conditions. Permeation profiles of PR in pig skin are illustrated in Fig. 8A. Permeation of PR was evident 
from 8 h for DMI, however the permeation of PR was not detected for PG and glycerol solutions until 12h. 
The cumulative amounts of PR that permeated from DMI and PG at 24 h were 12.9 ± 1.7 and 11.0 ± 6.3 
g/cm2, respectively (p>0.05). A significantly lower amount of PR was delivered from glycerol (4.3 ± 2.1 
g/cm2) compared with DMI (p<0.05).  
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Results for the mass balance studies are summarized in Table II. The recovery of PR from pig skin surface 
for PG and glycerol were 17.8±7.3 and 17.3±5.4%, respectively (p>0.05). Comparing to PG and glycerol, 
a lower recovery from the skin surface was evident for DMI solution, at 2.6±1.3% (p<0.05). The results 
also confirmed that more than 70% of the applied doses of PR were delivered into porcine skin at 24 h for 
three tested solutions. The amounts of PR extracted from pig skin after the permeation study accounted 
for 57.7±7.9, 53.8±9.1 and 48.9±8.1 % of applied PR for PG, DMI and glycerol solutions, respectively. 
There is no significant difference among these values (p>0.05).  
 
With reference to permeation studies conducted in human skin the PG solutions were more effective than 
DMI and glycerol solutions (Fig. 8B). Permeation of PR was detected from PG at 6 h. The cumulative 
permeation of PR from PG at 24 h was 10.2±3.1 g/cm2. This value was significantly higher than DMI 
(9.1±2.3 g/cm2) and glycerol (2.5±0.2 g/cm2) solutions (p<0.05).  
 
Table II summarized the results of mass balance studies. 22% of the applied dose of PR permeated through 
the epidermis for the PG solution. PG is the most commonly used glycol in transdermal and topical 
formulations, and it may act as a co-solvent and/or a permeation enhancer. Although the mechanism of 
PG penetration enhancement is not fully understood, it has been suggested that PG integrates into the 
polar regions of the lipids in the stratum corneum, disrupting the lamellar phase [40, 41]. DMI delivered 
19 % of the applied dose of PR through human skin. DMI is a water-miscible liquid with a relatively low 
viscosity; it has also exhibited potential as a good solvent for non-polar molecules [42]. The permeation 
enhancement of DMI was also observed in skin delivery of niacinamide [25]. Glycerol solutions delivered 
5 % of the applied PR through human skin (p>0.05). Unlike the permeation behavior observed in pig skin, 
a high percentage of PR was recovered from the human epidermal surface (Table II). The differences 
between the recovered percentages from human and pig skin surfaces were statistically significant for 
DMI and glycerol (p<0.05). The amount of PR extracted from porcine skin membrane was higher than the 
human skin retention for three tested solutions (p<0.05). For glycerol, 78% of the applied amount of PR 
remained on the skin surface, and 9% of the applied dose was extracted from human epidermis. Results for 
skin extraction of PR for DMI and PG indicated that 34 and 12% of the applied doses were retained within 
skin, respectively (p>0.05). For all tested solutions, the total recovery of PR was > 90%. This was within 
the acceptable range of the relevant OECD guidelines [35] 
 
For the three tested PR solutions, the cumulative permeated amount through full thickness porcine skin 
was within the range of 4 to 13 g/cm2, while the corresponding amount in human skin ranged from 2 to 
10 g/cm2. When compare PR permeation in two models, the difference was only evident for DMI solution, 
a higher permeation in porcine skin (13 g/cm2) than human skin (9 g/cm2) (p<0.05). In human skin 
studies, for three tested solutions, more than 45% of applied PR was recovered from the skin surface. 
Significant differences were evident for the surface recovered percentages between DMI and glycerol 
solutions (p<0.05). The skin extraction values between all three tested vehicles were different (p<0.05), 
ranged from 9 to 34% of dosed amounts. The higher amounts found on the surface in the human skin 
studies warrants further investigation. If these amounts can be reduced by judicious formulation, more 
effective products that deliver actives into the skin can be produced. 
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The lower permeability of human skin compared with porcine skin is in line with findings reported by other 
researchers [25, 36, 43, 44]. However, the differences between PR permeated though human epidermis 
and pig skin were not statistically significant for PG and glycerol solutions (p>0.05). The pig skin used in 
this study included epidermal and dermal layers. For human skin, only heat separated epidermis was used. 
The hydrated dermal layer in full thickness porcine skin may be expected to act as an additional aqueous 
barrier for PR permeation [43]. This could explain the higher skin retention observed in porcine skin 
compared to human skin (P<0.05). The higher retention in pig skin membrane was also consistent with the 
results reported by others [36]. From the results obtained in this study, the permeability of human and 
porcine skin clearly is dependent on the molecule of interest. Human skin remains the “gold-standard” to 
evaluate the skin delivery of chemicals for transdermal and topical purposes researchers [45]. However, 
porcine skin, whilst not a perfect model to predict human skin permeation is a suitable model to assess PR 
mammalian skin permeation before progressing to studies in human skin [43, 46, 47].  
 
Conclusions 
The characterization of the physicochemical properties of an active ingredient provides valuable 
information for development of a topical preparation of the material. To our knowledge this is the first 
study that reports a systematic characterization of PR. A new HPLC analytical method for the 
quantification of PR was developed and validated. The solubility and short-term stability of PR were 
investigated in varied solvents. Thermal analysis confirmed the melting point of PR as 79.1 °C. The 
permeation of PR was also investigated in porcine and human skin under finite dose conditions. The 
permeation behavior of PR observed in both human and porcine skin from three tested solution were 
consistent with the  physicochemical properties for its skin penetration, namely the < 300 Da, melting 
point < 100 °C , and a favourable partition coefficient. Considering the application of this active, skin 
retention of PR rather than skin permeation into the deeper tissue is desirable. Further study is required 
to examine more complex formulations with combinations of solvents to probe how skin delivery of PR 
may be further optimised.      
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Table I. The solubility of PR in a series of vehicles, HPLC water and PBS solution (n=3, mean±SD). 
 
 
 
 
 
 
 
 
Table II. The percentage of PR recovered from applied dose after mass balance in porcine skin and human 
epidermis for application of 1% (w/v) PR in DMI, PG and glycerol (4≤n≤5, mean±SD). 
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Figure 1. Biosynthetic pathway of melanin. Eumelanin and pheomelanin are synthesized with a series of 
reactions that are catalyzed by melanogenic enzymes. Hydroxylation of tyrosine to L-DOPA is the rate-
limiting step catalyzed by tyrosinase; TRP-1 and TRP-2 are also involved in eumelanogenesis. This figure 
was adopted (1) and modified. (TYR, tyrosinase; DQ, dopaquinone; L-Dopa, L-3,4-dihydroxyphenylalanine; 
DHICA, 5,6-dihydroxyindole-2 carboxylic acid; DHI, 5,6-dihydroxyindole; ICAQ, indole-2-carboxylic acid-
5,6-quinone; IQ, indole-5,6-quinone, TRP-1, tyrosinase-related protein 1; TRP-2, tyrosinase-related protein 
2). 
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Figure 2. The 2D structure of phenylethyl resorcinol. 
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  Figure 3. 1H NMR (A) and 13C NMR (B) spectrum of PR in d-chloroform. 
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Figure 4. Thermogravimetric analysis (TGA) of PR from 40 to 400 ºC with a heating ramp of 20 ºC/min. 
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Figure 5. Differential scanning calorimetry (DSC) analysis of PR from 0 to 150 ºC with a heating ramp of 10 
ºC/min. 
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Figure 6. Percentage of weight loss over 1440 min from 1% PR solution in DMI, PG and Glycerol as prepared 
for human skin and porcine skin permeation studies. n=3, mean±SD. 
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Figure 7. the results of the stability studies of PR in PG, DMI, glycerol, and the PBS solution for up to 72 h. 
n=3, mean±SD. 
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Figure 8. The permeation profiles of PR through porcine skin (A) and human skin (B) under finite dose 
application of 1% (w/v) PR in PG (■), DMI (●) and Glycerol (◆). 4≤n≤5, mean±SD. 
